First AD

Second AD

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Evolving Treatment Patterns in Breast Cancer

Peer Exchange

Chemoimmunotherapy in TNBC: The IMpassion130 Trial 

A Background on Early HER2+ Breast Cancer 

HER2+ Breast Cancer: The KATHERINE Trial 

HER2+ Breast Cancer: Use of Weekly Paclitaxel-Trastuzumab 

Pathologic Complete Response in HER2+ Breast Cancer

Current State of CDK4/6 Inhibition in HR+ mBC 

HR+ Metastatic Breast Cancer: Upfront CDK4/6 Inhibition 

Making Sense of Adjuvant Therapy in HER2+ Breast Cancer 

HER2+ Breast Cancer: Neratinibs Role as Adjuvant Therapy 

Moving CDK4/6 Inhibition to HER2+ Breast Cancer 

Combining PARP and Checkpoint Inhibitors in TNBC 

Antibody-Drug Conjugates in TNBC: Sacituzumab Govitecan  

Questioning CDK4/6 Inhibitor Cross-Resistance in HR+ mBC 

Chemoimmunotherapy in TNBC: The KEYNOTE-355 Trial 